2009Zhongguo linchuang yixueRequires access

A Prospective Study of Comparing Marvelon/GnRH-agonist Leuprorelin Acetate and Danazol in the Treatment of Endometriosis after Operation

XU Yindi

Open publisher page 0 citations

Abstract

Objective:To evaluate the safety and efficacy of the oral contraceptive marvelon on preventing the recurrence of post-surgery endometriosis. Methods182 endometriosis patients after conservative surgery were divided into three groups: Marvelon group ,GnRH-agonist leuprorelin acetate group and Danazol group. Their pain score,endometriosis mass,reproductive hormone ,serum CA125 level and side effects were recorded. Results:The recurrence rate of Marvelon group and GnRH-agonist group were significantly lower than that of Danazol group and side effects of Marvelon group were lowest in the three groups. Reproductive hormone and serum CA 125 level were significantly degraded in all three groups. Conclusion:Compared with Danazol and GnRH-agonist,Marvelon is a drug with high efficacy and safety for endometriosis and should be recommended as first choice for preventing the recurrence of post-surgery endometriosis.

About this research paper

What this paper is about

Objective:To evaluate the safety and efficacy of the oral contraceptive marvelon on preventing the recurrence of post-surgery endometriosis. Methods182 endometriosis patients after conservative surgery were divided into three groups: Marvelon group ,GnRH-agonist leuprorelin acetate group and Danazol group. Their pain score,endometriosis mass,reproductive hormone ,serum CA125 level and side effects were recorded. Results:The recurrence rate of Marvelon group and GnRH-agonist group were significantly lower than that of Danazol group and side effects of Marvelon group were lowest in the three groups. Reproductive hormone and serum CA 125 level were significantly degraded in all three groups. Conclusion:Compared with Danazol and GnRH-agonist,Marvelon is a drug with high efficacy and safety for endometriosis and should be recommended as first choice for preventing the recurrence of post-surgery endometriosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the safety and efficacy of the oral contraceptive marvelon on preventing the recurrence of post-surgery endometriosis. Methods182 endometriosis patients after conservative surgery were divided into three groups: Marvelon group ,GnRH-agonist leuprorelin acetate group and Danazol group. Their pain score,endometriosis mass,reproductive hormone ,serum CA125 level and side effects were recorded. Results:The recurrence rate of Marvelon group and GnRH-agonist group were significantly lower than that of Danazol group and side effects of Marvelon group were lowest in the three groups. Reproductive hormone and serum CA 125 level were significantly degraded in all three groups. Conclusion:Compared with Danazol and GnRH-agonist,Marvelon is a drug with high efficacy and safety for endometriosis and should be recommended as first choice for preventing the recurrence of post-surgery endometriosis.

Key concepts: Leuprorelin, Danazol, Medicine, Endometriosis, Triptorelin, Agonist, Gonadotropin-releasing hormone agonist, Gynecology

Related papers

Back to paper searchBrowse research topicsOriginal source
A Prospective Study of Comparing Marvelon/GnRH-agonist Leuprorelin Acetate and Danazol in the Treatment of Endometriosis after Operation — Research Paper | ScholarLens